Outlook Therapeutics (OTLK) Shares Outstanding (Weighted Average): 2015-2024
Historic Shares Outstanding (Weighted Average) for Outlook Therapeutics (OTLK) over the last 10 years, with Sep 2024 value amounting to $23.7 million.
- Outlook Therapeutics' Shares Outstanding (Weighted Average) rose 350.47% to $6.4 million in Q3 2020 from the same period last year, while for Jun 2020 it was $4.6 million, marking a year-over-year increase of 313.48%. This contributed to the annual value of $23.7 million for FY2024, which is 81.80% up from last year.
- Outlook Therapeutics' Shares Outstanding (Weighted Average) amounted to $23.7 million in FY2024, which was up 81.80% from $13.0 million recorded in FY2023.
- In the past 5 years, Outlook Therapeutics' Shares Outstanding (Weighted Average) registered a high of $23.7 million during FY2024, and its lowest value of $6.4 million during FY2020.
- In the last 3 years, Outlook Therapeutics' Shares Outstanding (Weighted Average) had a median value of $13.0 million in 2023 and averaged $16.0 million.
- Data for Outlook Therapeutics' Shares Outstanding (Weighted Average) shows a peak YoY soared of 350.47% (in 2020) over the last 5 years.
- Yearly analysis of 5 years shows Outlook Therapeutics' Shares Outstanding (Weighted Average) stood at $6.4 million in 2020, then surged by 37.87% to $8.8 million in 2021, then rose by 28.97% to $11.3 million in 2022, then grew by 15.08% to $13.0 million in 2023, then spiked by 81.80% to $23.7 million in 2024.